Mitochondria May Be the Brain’s Secret Sleep Switch

By World Mitochondria Society 

Why do we feel so tired when we don’t sleep?

A new study published in Nature suggests the answer may lie deep inside our brain cells, specifically in their mitochondria, the tiny energy-producing structures often called the cell’s “powerhouses.”
Researchers from the University of Oxford found that when fruit flies were sleep-deprived, a specific group of brain cells showed dramatic changes in their mitochondria. These neurons, which help control the urge to sleep, responded to sleep loss by ramping up energy production and reorganizing their internal machinery.

Mitochondria and Sleep Pressure

They discovered that sleep pressure, what makes us feel sleepy, builds up when mitochondria in key neurons become overworked. 
After rest, these changes reversed, suggesting that mitochondria help the brain recover. Even more striking, the scientists were able to dial sleepiness up or down by changing how the mitochondria worked.
When the mitochondria were forced to split into smaller fragments, the flies slept less. When mitochondria were fused into longer structures, the flies felt a stronger need to sleep.

This discovery adds a surprising new piece to the puzzle of sleep science. Until now, sleep was mostly studied as a brain-wide process involving electrical signals or chemical messengers. But this study shows that the buildup of sleep pressure might begin with stress inside individual brain cells.

What’s next?

This research could one day help scientists design treatments for sleep disorders by targeting mitochondrial health. It also opens the door to rethinking sleep not just as a brain state, but as a metabolic response to cellular energy needs.

A new study published in Nature by Gero Miesenböch : https://www.nature.com/articles/s41586-025-09261-y

Cancer’s Energy Hack: Tumor Cells Steal Mitochondria from Nerves to Fuel Metastasis

In a striking new study published in Nature, researchers reveal that cancer cells can directly siphon mitochondria from nearby nerve cells — gaining a powerful metabolic edge that helps them spread throughout the body.

A surprising neural alliance

It’s long been known that nerves infiltrate tumors and somehow enhance cancer progression. But the exact mechanism was unclear. This new research, led by Dr. Simon Grelet, shows that neurons surrounding tumors actively produce extra mitochondria and transfer them to cancer cells via nanotubes — thin, tube-like cellular extensions.

These donated mitochondria aren’t damaged or dysfunctional; they’re fully operational, supercharging the cancer cells’ metabolism and helping them survive and proliferate under stress.

A new tool: the MitoTRACER

To track this process, the team developed a genetic sensor called MitoTRACER, which irreversibly labels cancer cells that have absorbed mitochondria from neurons.
In mouse models of breast cancer, these mitochondria-receiving cells were vastly overrepresented in metastatic sites — clear evidence that neuronal mitochondria play a critical role in cancer spread.

Confirmed in human tumors

The findings were validated in human prostate cancer tissue samples. Areas with high nerve density showed more mitochondrial content in nearby cancer cells. Moreover, chemically disrupting the neural supply using botulinum toxin (BoNT/A) reduced the mitochondrial transfer and impaired cancer aggressiveness.

Why it matters :
    •    A new metabolic weapon: Cancer cells aren’t just reprogramming their own metabolism — they’re outsourcing energy production by stealing power plants from neurons.
    •    Direct link to metastasis: The mitochondrial boost gives cancer cells the fuel they need to survive oxidative stress and adapt during metastasis.
    •    A new therapeutic frontier: Targeting the neuron–tumor interaction — by blocking nanotube formation or preventing mitochondrial trafficking — could offer a novel way to slow or stop cancer spread.

More information :
Grelet et al., “Neuronal–tumour cell mitochondrial transfer promotes metastasis,” Nature, 26 June 2025, DOI: 10.1038/s41586-025-09176-8.

Read the article

How Mitochondria Can Be Matched to Pathology

From Powerhouse to Precision Tool in Regenerative Medicine

Mitochondrial transplantation is rapidly emerging as a groundbreaking strategy in precision medicine. A recent study published in Cell Death & Disease demonstrates that mitochondria sourced from different cell types and species can exert distinct therapeutic effects, depending on the nature of cellular stress or damage—supporting the concept of pathology-matched mitochondrial therapy.

Led by Xiaomeng Lu the study demonstrates that mitochondria sourced from diverse species (canine, porcine, bovine, etc.) can be safely transplanted into stressed immune and cardiac cells, and even into live animal models, without triggering an immune response. More importantly, these transplanted mitochondria conferred distinct, context-dependent protective effects based on their origin—suggesting a future of tailored mitochondrial therapies.

This approach, referred to as adaptive bioenhancement, proposes that donor mitochondria can be selected or engineered to match the metabolic or immunological needs of specific diseases. The implications are profound: mitochondria are no longer seen merely as cellular batteries, but as programmable organelles capable of restoring balance in a targeted fashion.

Key Concepts Illustrated
    •    Cross-species delivery is safe and effective: The study found that mitochondria from various mammalian cells were well tolerated in both cell cultures and live mice—even across species barriers.
    •    Disease-specific matching is possible:
    •    Neurodegeneration: Mitochondria rich in antioxidant and synaptic-support functions.
    •    Cardiomyopathy: High-energy, calcium-buffering mitochondria.
    •    Sepsis & inflammation: ROS-scavenging, immunomodulatory mitochondria.
    •    Designer mitochondria: Fusion of mitochondrial populations (e.g. HL1 + H9C2) enhanced key proteins (Opa1, Drp1, Mfn1), enabling mitochondrial performance to be optimized for specific stress contexts.

In Vivo Confirmation

In a mouse model of LPS-induced acute inflammation, tail-vein injection of wild-derived mitochondria:
    •    Boosted grip strength and endurance
    •    Reduced IL‑6, TNF‑α, and IL‑10 serum levels
    •    Normalized liver and kidney function markers
    •    Reduced tissue ROS and lipid peroxidation

Global Perspective – Berlin 2025

This emerging concept of pathology-matched mitochondrial therapy will be at the forefront of the World Mitochondria Society (WMS) Annual Meeting, to be held in Berlin this October. 

WMS continues to serve as the global platform for shaping the future of mitochondrial research and therapeutic innovation.

Reference

Xiaomeng Lu - Mitochondrial transplantation: adaptive bio-enhancement. Cell Death & Disease. 2025;15(7):309. https://doi.org/10.1038/s41419-025-07643-8

A Chimera that Breaches Mitochondria

A Chimera that Breaches Mitochondria
A milestone in mitochondrial biology

A research team from the University Medical Center Göttingen has developed a synthetic chimera that can cross both mitochondrial membranes and selectively block mitochondrial protein synthesis—without altering nuclear DNA.

For the first time, scientists can now disable one mitochondrial protein at a time in living cells, enabling real-time study of bioenergetics, redox balance, and disease pathways.

This innovation bypasses long-standing genetic barriers and opens new possibilities for studying and treating mitochondrial dysfunction in aging, neurodegeneration, and metabolic disease.